Physiologically‐Based Pharmacokinetic Modeling of the Drug-Drug Interaction of the UGT Substrate Ertugliflozin Following Co‐Administration with the UGT Inhibitor Mefenamic Acid
The sodium‐glucose cotransporter 2 inhibitor ertugliflozin is metabolized by the uridine 5'‐diphospho‐glucuronosyltransferase (UGT) isozymes UGT1A9 and UGT2B4/2B7. This analysis evaluated the drug-drug interaction (DDI) following co‐administration of ertugliflozin with the UGT inhibitor mefenam...
Saved in:
Main Authors: | Ernesto Callegari (Author), Jian Lin (Author), Susanna Tse (Author), Theunis C. Goosen (Author), Vaishali Sahasrabudhe (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Physiologically Based Pharmacokinetic Modelling of UGT Substrate Drugs Lamotrigine and Raltegravir during Pregnancy
by: Monika Berezowska, et al.
Published: (2024) -
End‐to‐end application of model‐informed drug development for ertugliflozin, a novel sodium‐glucose cotransporter 2 inhibitor
by: Daryl J. Fediuk, et al.
Published: (2021) -
Profiling of UGT1A1*6, UGT1A1*60, UGT1A1*93, and UGT1A1*28 Polymorphisms in Indonesian Neonates With Hyperbilirubinemia Using Multiplex PCR Sequencing
by: Radhian Amandito, et al.
Published: (2019) -
Commentary: Profiling of UGT1A1*6, UGT1A1*60, UGT1A1*93, and UGT1A1*28 Polymorphisms in Indonesian Neonates With Hyperbilirubinemia Using Multiplex PCR Sequencing
by: Mohammad Reza Heydari, et al.
Published: (2020) -
Genotyping of <i>UGT1A1*</i>80 as an Alternative to <i>UGT1A1*</i>28 Genotyping in Spain
by: Adrián Bravo-Gómez, et al.
Published: (2022)